News

LSP leads €67m [$75m] Series A financing in Alizé Pharma 3 read full story

LSP portfolio company Binx Health to receive 510(k) marketing authorization for its io- system view video

LSP leads € 116 million financing in AM-Pharma read full story

LSP leads $38.5 Million Series B Financing in DNA Script read full story

LSP leads € 28 million Series B financing in Imcyse read full story

"De Tijd" - Biotech company Imcyse gives hope to patients with diabetes and MS read full story

Okairos winner of the Swiss Biotech Success Stories Awards 2018/19 read full story

LSP co-leads $50 million Series A financing in SNIPR BIOME read full story

LSP leads $180 million Series A Financing in Newly-Formed Arvelle Therapeutics read full story

LSP raises record €750 million in 10 months for life sciences innovations

EMA making its first public appearance at our conference read full story

LSP Life Sciences Fund Performing strongly and ending Q1 2019 up +17.5% read full story

Immunic Therapeutics and Vital Therapies complete transaction creating Nasdaq-listed company read full story

LSP on BNR by Marco Groot (around Minute 3:00) listen to audio

Go to archive

MONTHLY REPORTS